Melissa Geddie
Senior Vice President, Drug Discovery Diagonal Therapeutics
Melissa is the SVP of drug discovery at Diagonal Therapeutics joining us from Biogen. She has over 15 years of experience designing and characterizing novel antibody therapeutics from early discovery to investigational new drug submissions. Melissa has also worked at Kiniksa Pharmaceuticals and Merrimack Pharmaceuticals in their early discovery groups. She was a postdoctoral fellow at the Whitehead Institute and received her Ph.D. in Biochemistry from Emory University.
Seminars
Thursday 12th November 2026
Round Table: Closing the Design-Build-Test-Learn Loop for Multispecific Antibody Discovery & Candidate Selection
9:40 am
- Combining computational and experimental workflows to identify and refine bispecific candidates
- Determining what data is most valuable for informing and improving protein design models
- Building effective feedback loops between in silico prediction and experimental validation
- Key challenges in translating engineered multispecific antibodies from discovery through candidate selection
